As of May 22
| +0.05 / +0.36%|
The 13 analysts offering 12-month price forecasts for Ironwood Pharmaceuticals Inc have a median target of 15.00, with a high estimate of 21.00 and a low estimate of 9.00. The median estimate represents a +8.46% increase from the last price of 13.83.
The current consensus among 13 polled investment analysts is to Hold stock in Ironwood Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.